Social Media Listening for Routine Post-Marketing Safety Surveillance

被引：0
|
作者：
Gregory E. Powell
Harry A. Seifert
Tjark Reblin
Phil J. Burstein
James Blowers
J. Alan Menius
Jeffery L. Painter
Michele Thomas
Carrie E. Pierce
Harold W. Rodriguez
John S. Brownstein
Clark C. Freifeld
Heidi G. Bell
Nabarun Dasgupta
机构：
[1] GlaxoSmithKline,
[2] GlaxoSmithKline Vaccines,undefined
[3] GlaxoSmithKline,undefined
[4] GlaxoSmithKline,undefined
[5] Blue Zone Industries,undefined
[6] Epidemico Inc.,undefined
[7] Zero Chaos,undefined
来源：
Drug Safety | 2016年 / 39卷
关键词：
Social Medium; Anatomical Therapeutic Chemical; Indicator Score; Proportional Reporting Ratio; Twitter Data;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：443 / 454
页数：11
相关论文
共 50 条
  • [41] The safety of quetiapine: results of a post-marketing surveillance study on 1728 patients in England
    Twaites, Beverley R.
    Wilton, Lynda V.
    Shakir, Saad A. W.
    [J]. JOURNAL OF PSYCHOPHARMACOLOGY, 2007, 21 (04) : 392 - 399
  • [42] Growth Hormone Post-Marketing Surveillance: Safety, Sales, and the Unfinished Task Ahead
    Allen, David B.
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2010, 95 (01): : 52 - 55
  • [43] Safety analysis of Epzicom ® (lamivudine/abacavir sulfate) in post-marketing surveillance in Japan
    Kurita, Tomoko
    Kitaichi, Tomomi
    Nagao, Takako
    Miura, Toshiyuki
    Kitazono, Yoshifumi
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2014, 23 (04) : 372 - 381
  • [44] Analyzing the US Post-marketing safety surveillance of COVID-19 vaccines
    Albalawi, Omar M.
    Alomran, Maha, I
    Alsagri, Ghada M.
    Althunian, Turki A.
    Alshammari, Thamir M.
    [J]. SAUDI PHARMACEUTICAL JOURNAL, 2022, 30 (02) : 180 - 184
  • [45] Safety/Efficacy of Prucalopride in Korean Patients with Chronic Constipation: Post-marketing Surveillance
    Yeon, Sang Eun
    Kim, Su Youn
    Chung, Woo Chul
    Jeon, Seong Woo
    Park, Soo Jung
    Choi, Chang Hwan
    Choi, Myung Gyu
    [J]. KOREAN JOURNAL OF GASTROENTEROLOGY, 2021, 78 (04): : 219 - 226
  • [46] POST-MARKETING SURVEILLANCE OF THE SAFETY OF CIMETIDINE - 12-MONTH MORBIDITY REPORT
    JONES, DGC
    LANGMAN, MJS
    LAWSON, DH
    VESSEY, MP
    [J]. QUARTERLY JOURNAL OF MEDICINE, 1985, 54 (215): : 253 - 268
  • [47] Utility of electronic health records to support post-marketing drug safety surveillance
    Lin, Nancy D.
    Calderbank, Jenna
    Anderson, David
    Seeger, John
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2020, 29 : 415 - 415
  • [48] Safety and Effectiveness of Varenicline in Korean Smokers: A Nationwide Post-Marketing Surveillance Study
    Ra, S.
    Shin, J.
    Ock, M.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2019, 199
  • [49] Safety of measles-containing vaccines in post-marketing surveillance in Anhui, China
    Meng, Fan-Ya
    Sun, Yong
    Shen, Yong-Gang
    Pan, Hai-Feng
    Tang, Ji-Hai
    Wang, Bin-Bing
    Wu, Chang-Hao
    Ye, Dong-Qing
    [J]. PLOS ONE, 2017, 12 (02):
  • [50] Safety and Effectiveness of Varenicline in Korean Smokers: A Nationwide Post-Marketing Surveillance Study
    Ock, Minsu
    Shin, Ji Soo
    Ra, Seung Won
    [J]. PATIENT PREFERENCE AND ADHERENCE, 2022, 16 : 413 - 426
12345